FT News Briefing Wednesday, April 3
Apr 3, 2019
Theresa May is considering a dialogue with Jeremy Corbyn to explore a softer Brexit approach. In the U.S., drug prices are skyrocketing, despite bipartisan pressures. Additionally, the world's leading energy organization faces backlash for its fossil-friendly strategies. The discussion also dives into leadership changes at BlackRock and their pivot towards alternative investments amidst a competitive landscape, highlighting a shift in asset management towards technology-driven solutions.
AI Snips
Chapters
Transcript
Episode notes
May's Brexit Gambit
- Theresa May proposed talks with Labour leader Jeremy Corbyn on a softer Brexit deal.
- This move angered Eurosceptics within her party, who fear a split and Labour gaining power.
Soaring Drug Prices
- Despite bipartisan pressure, US drug prices continue to rise, with some companies enacting substantial increases.
- Acorn, for instance, raised the price of an anesthetic jelly by 285%, citing market dynamics and rising costs.
IEA Under Fire
- The International Energy Agency faces criticism for its "fossil-friendly" climate forecasts.
- Critics argue that its models don't align with the Paris Agreement's goal of limiting temperature increases.